BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zabel M, Willems R, Lubinski A, Bauer A, Brugada J, Conen D, Flevari P, Hasenfuß G, Svetlosak M, Huikuri HV, Malik M, Pavlović N, Schmidt G, Sritharan R, Schlögl S, Szavits-Nossan J, Traykov V, Tuinenburg AE, Willich SN, Harden M, Friede T, Svendsen JH, Sticherling C, Merkely B; EU-CERT-ICD Study Investigators. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study. Eur Heart J 2020;41:3437-47. [PMID: 32372094 DOI: 10.1093/eurheartj/ehaa226] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Barra S, Narayanan K, Garcia R, Marijon E. Time to revisit implantable cardioverter-defibrillator implantation criteria in women. Eur Heart J 2021;42:1110-2. [PMID: 33367695 DOI: 10.1093/eurheartj/ehaa970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lombardo L, Wynne R, Hickman L, Ferguson C. New technologies call for new strategies for patient education. Eur J Cardiovasc Nurs 2021;20:399-401. [PMID: 33847350 DOI: 10.1093/eurjcn/zvab026] [Reference Citation Analysis]
3 Younis A, Goldberger JJ, Kutyifa V, Zareba W, Polonsky B, Klein H, Aktas MK, Huang D, Daubert J, Estes M, Cannom D, McNitt S, Stein K, Goldenberg I. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score. Eur Heart J 2021;42:1676-84. [PMID: 33417692 DOI: 10.1093/eurheartj/ehaa1057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Zabel M, Friede T, Huikuri H, Malik M, Willems R. Role of the proportion of sudden cardiac death to mortality for clinical effectiveness of primary prevention ICDs. Eur Heart J 2020;41:4527-8. [PMID: 32995841 DOI: 10.1093/eurheartj/ehaa630] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Younis A, Aktas MK, Lee D, Zareba W, McNitt S, Polonsky B, Kutyifa V, Rosero S, Huang D, Vidula H, Goldenberg I. Hospitalization for Heart Failure and Subsequent Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction. JACC Clin Electrophysiol 2021:S2405-500X(21)00121-3. [PMID: 33812828 DOI: 10.1016/j.jacep.2021.01.021] [Reference Citation Analysis]
6 Disertori M, Masè M, Rigoni M, Ravelli F, Nollo G. The paradox of implantable cardioverter-defibrillator: When guidelines may play against care improvement. Am Heart J 2021;233:149-50. [PMID: 33610194 DOI: 10.1016/j.ahj.2020.11.012] [Reference Citation Analysis]
7 Crijns HJGM, Prinzen F, Lambiase PD, Sanders P, Brugada J. The year in cardiovascular medicine 2020: arrhythmias. Eur Heart J 2021;42:499-507. [PMID: 33388752 DOI: 10.1093/eurheartj/ehaa1091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mark Estes NA, Saba S. Primary prevention of sudden death with the implantable cardioverter defibrillator: bridging the evidence gap. Eur Heart J 2020;41:3448-50. [PMID: 32424399 DOI: 10.1093/eurheartj/ehaa324] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Dommasch M, Steger A, Barthel P, Huster KM, Müller A, Sinnecker D, Laugwitz KL, Penzel T, Lubinski A, Flevari P, Harden M, Friede T, Kääb S, Merkely B, Sticherling C, Willems R, Huikuri HV, Bauer A, Malik M, Zabel M, Schmidt G; EU-CERT-ICD investigators. Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study. EClinicalMedicine 2021;31:100695. [PMID: 33554086 DOI: 10.1016/j.eclinm.2020.100695] [Reference Citation Analysis]
10 Smoczyńska A, Loen V, Sprenkeler DJ, Tuinenburg AE, Ritsema van Eck HJ, Malik M, Schmidt G, Meine M, Vos MA. Short-Term Variability of the QT Interval Can be Used for the Prediction of Imminent Ventricular Arrhythmias in Patients With Primary Prophylactic Implantable Cardioverter Defibrillators. J Am Heart Assoc 2020;9:e018133. [PMID: 33215550 DOI: 10.1161/JAHA.120.018133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ruwald MH, Ruwald AC, Johansen JB, Gislason G, Lindhardt TB, Nielsen JC, Torp-Pedersen C, Riahi S, Vinther M, Philbert BT. Temporal Incidence of Appropriate and Inappropriate Therapy and Mortality in Secondary Prevention ICD Patients by Cardiac Diagnosis. JACC Clin Electrophysiol 2021;7:781-92. [PMID: 33516705 DOI: 10.1016/j.jacep.2020.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Curtain JP, Docherty KF, Jhund PS, Petrie MC, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Bengtsson O, Langkilde AM, Sjöstrand M, Solomon SD, McMurray JJV. Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF. Eur Heart J 2021;42:3727-38. [PMID: 34448003 DOI: 10.1093/eurheartj/ehab560] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
13 Crea F. Prediction of sudden death in the era of personalized medicine. Eur Heart J 2021;42:1641-4. [PMID: 34009319 DOI: 10.1093/eurheartj/ehab215] [Reference Citation Analysis]
14 Lüscher TF. Sudden cardiac death: addressing unresolved issues. Eur Heart J 2020;41:1947-51. [PMID: 33216866 DOI: 10.1093/eurheartj/ehaa490] [Reference Citation Analysis]